Wednesday, November 07, 2018 1:57:29 PM
I think those figures represent the potential. How close we can get is the question.
There is an estimate that California represents a testing market of $90 to $100 million presently... EVIO has 1/3 of the accredit labs in the state... but I don't think that means we can extrapolate to a $30 million potential revenue base for EVIO... maybe $5 to $10 million initially? but across all the markets they're in, I can't see why they shouldn't be doing meaningful revenues, with positive cashflow, by middle of 2019.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM